MORF - Morphic Holding Inc
IEX Last Trade
58.29
1.880 3.225%
Share volume: 330,544
Last Updated: Tue 08 Aug 2023 09:59:59 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$56.41
1.88
3.33%
View ratios
Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | |
Report Date | 2022-05-04 | 2022-08-03 | 2022-11-02 | 2023-02-23 | 2023-04-25 | 2023-08-03 | 2023-11-03 | 2024-02-22 | |
Total revenue | 2.382 M | 60.236 M | 2.055 M | 6.135 M | 521.000 K | 0.000 | 0.000 | 0.000 | |
Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Gross profit | 2.382 M | 60.236 M | 2.055 M | 6.135 M | 521.000 K | 0.000 | 0.000 | 0.000 | |
2,428.80% | -96.59% | 198.54% | -91.51% | -100.00% | nan% | nan% | |||
Operating expenses | 34.054 M | 33.886 M | 33.548 M | 32.716 M | 39.726 M | 45.302 M | 44.748 M | 49.431 M | |
Selling general and admin | 7.591 M | 8.234 M | 8.303 M | 8.014 M | 9.277 M | 9.583 M | 10.384 M | 9.579 M | |
Research and development | 26.463 M | 25.652 M | 25.245 M | 24.702 M | 30.449 M | 35.719 M | 34.364 M | 39.852 M | |
Total expenses | 34.054 M | 33.886 M | 33.548 M | 32.716 M | 39.726 M | 45.302 M | 44.748 M | 49.431 M | |
-0.49% | -1.00% | -2.48% | 21.43% | 14.04% | -1.22% | 10.47% | |||
Operating income | -31.672 M | 26.350 M | -31.493 M | -26.581 M | -39.205 M | -45.302 M | -44.748 M | -49.431 M | |
Ebit | -31.672 M | 26.350 M | -31.493 M | -26.581 M | -39.205 M | -45.302 M | -44.748 M | -49.431 M | |
Pretax income | -31.484 M | 26.843 M | -29.992 M | -24.341 M | -36.103 M | -38.875 M | -36.129 M | -40.608 M | |
-185.26% | -211.73% | -18.84% | 48.32% | 7.68% | -7.06% | 12.40% | |||
Income tax | 0.000 | 2.000 K | 29.000 K | 36.000 K | 32.000 K | 138.000 K | 83.000 K | 127.000 K | |
Net income basic | -31.484 M | 26.841 M | -30.021 M | -24.377 M | -36.135 M | -39.013 M | -36.212 M | -40.735 M | |
185.25% | -211.85% | 18.80% | -48.23% | -7.96% | 7.18% | -12.49% | |||
Net income | -31.484 M | 26.841 M | -30.021 M | -24.377 M | -36.135 M | -39.013 M | -36.212 M | -40.735 M | |
185.25% | -211.85% | 18.80% | -48.23% | -7.96% | 7.18% | -12.49% |